Literature DB >> 27747059

LATITUDE-TIMI: is there still hope for anti-inflammatory therapy in acute myocardial infaction?

Matthias Dewenter1, Michael Wagner1, Ali El-Armouche1.   

Abstract

Year:  2016        PMID： 27747059      PMCID： PMC5059335          DOI： 10.21037/jtd.2016.08.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

Review 1.  New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease.

Authors:  Eva Denise Martin; Gian Felice De Nicola; Michael S Marber
Journal:  Circulation       Date:  2012-07-17       Impact factor: 29.690

2.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

Authors:  P M Ridker; N Rifai; M Pfeffer; F Sacks; S Lepage; E Braunwald
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

3.  Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

Authors:  Anne-Marie Schjerning Olsen; Gunnar H Gislason; Patricia McGettigan; Emil Fosbøl; Rikke Sørensen; Morten Lock Hansen; Lars Køber; Christian Torp-Pedersen; Morten Lamberts
Journal:  JAMA       Date:  2015-02-24       Impact factor: 56.272

4.  Meta-analysis of corticosteroid treatment in acute myocardial infarction.

Authors:  Gregory R Giugliano; Robert P Giugliano; C Michael Gibson; Richard E Kuntz
Journal:  Am J Cardiol       Date:  2003-05-01       Impact factor: 2.778

5.  Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.

Authors:  Florian Streitner; Juergen Kuschyk; Christian Veltmann; Desiree Ratay; Nina Schoene; Ines Streitner; Martina Brueckmann; Burghard Schumacher; Martin Borggrefe; Christian Wolpert
Journal:  Cytokine       Date:  2009-07-14       Impact factor: 3.861

Review 6.  The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction.

Authors:  Samantha D Francis Stuart; Nicole M De Jesus; Merry L Lindsey; Crystal M Ripplinger
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

7.  Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

Authors:  Michelle L O'Donoghue; Eugene Braunwald; Harvey D White; Dylan P Steen; Mary Ann Lukas; Elizabeth Tarka; P Gabriel Steg; Judith S Hochman; Christoph Bode; Aldo P Maggioni; KyungAh Im; Jennifer B Shannon; Richard Y Davies; Sabina A Murphy; Sharon E Crugnale; Stephen D Wiviott; Marc P Bonaca; David F Watson; W Douglas Weaver; Patrick W Serruys; Christopher P Cannon; Dylan L Steen
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

9.  Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

Authors:  Michelle L O'Donoghue; Ruchira Glaser; Matthew A Cavender; Philip E Aylward; Marc P Bonaca; Andrzej Budaj; Richard Y Davies; Mikael Dellborg; Keith A A Fox; Jorge Antonio T Gutierrez; Christian Hamm; Robert G Kiss; František Kovar; Julia F Kuder; Kyung Ah Im; John J Lepore; Jose L Lopez-Sendon; Ton Oude Ophuis; Alexandr Parkhomenko; Jennifer B Shannon; Jindrich Spinar; Jean-Francois Tanguay; Mikhail Ruda; P Gabriel Steg; Pierre Theroux; Stephen D Wiviott; Ian Laws; Marc S Sabatine; David A Morrow
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia.

Authors:  Joseph Cheriyan; Andrew J Webb; Lea Sarov-Blat; Maysoon Elkhawad; Sharon M L Wallace; Kaisa M Mäki-Petäjä; David J Collier; John Morgan; Zixing Fang; Robert N Willette; John J Lepore; John R Cockcroft; Dennis L Sprecher; Ian B Wilkinson
Journal:  Circulation       Date:  2011-01-24       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.